Fresenius reports a 13% drop in net profit to 1.5 billion euros for 2023, but a 3% rise in operating profit (EBIT) to 2.26 billion (+2% at constant exchange rates) on revenues up 4% to 22.3 billion (+6% organic).

The German healthcare services group thus confirms that it has achieved the guidance it revised upwards three months ago for the past financial year, having in particular achieved a strong fourth quarter and exceeded its annual cost savings target by around 40%.

Fresenius anticipates EBIT growth of between 4% and 8% for 2024, as well as organic sales growth of between 3% and 6%. It is also raising its EBIT cost savings target to around 400 million by 2025.

Copyright (c) 2024 All rights reserved.